Systematic lymphadenectomy for intermediate risk endometrial carcinoma treatment does not improve the oncological outcome
{{output}}
Objective: To evaluate the indication and performance of systematic lymphadenectomy (SL) in Stage I endometrioid endometrial carcinoma (EEC), at intermediate risk (FIGO IAG2/G3, IBG1/G2) on recurrence, disease-free survival (DFS)... ...
